- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.41 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x 4U9: 5-[4-bromo-2-(2-chloro-6-fluorophenyl)-1H-imidazol-5-yl]-2-{[4-(trifluoromethyl)phenyl]ethynyl}pyridine(Non-covalent)
- 3 x GSH: GLUTATHIONE(Non-covalent)
GSH.2: 13 residues within 4Å:- Chain A: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Chain B: A.27, T.30, R.34, L.65
- Ligands: 4U9.1
13 PLIP interactions:7 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: A:N.70, A:E.73, A:Y.113, A:Y.113, A:R.122
- Water bridges: A:N.70, A:Y.126, B:R.34, B:N.42, B:H.68, B:H.68
- Hydrophobic interactions: B:T.30
- Salt bridges: B:R.34
GSH.7: 13 residues within 4Å:- Chain B: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Chain C: A.27, T.30, R.34, L.65
- Ligands: 4U9.6
13 PLIP interactions:7 interactions with chain B, 6 interactions with chain C- Hydrogen bonds: B:N.70, B:E.73, B:Y.113, B:Y.113, B:R.122
- Water bridges: B:N.70, B:Y.126, C:R.34, C:N.42, C:H.68, C:H.68
- Hydrophobic interactions: C:T.30
- Salt bridges: C:R.34
GSH.12: 13 residues within 4Å:- Chain A: A.27, T.30, R.34, L.65
- Chain C: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Ligands: 4U9.11
13 PLIP interactions:7 interactions with chain C, 6 interactions with chain A- Hydrogen bonds: C:N.70, C:E.73, C:Y.113, C:Y.113, C:R.122
- Water bridges: C:N.70, C:Y.126, A:R.34, A:N.42, A:H.68, A:H.68
- Hydrophobic interactions: A:T.30
- Salt bridges: A:R.34
- 6 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
BOG.3: 7 residues within 4Å:- Chain A: L.131, A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.5
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.131, A:A.134
- Hydrogen bonds: A:S.135, A:Q.139
- Water bridges: A:S.135, A:S.135
BOG.4: 6 residues within 4Å:- Chain A: K.22, V.25, T.110, L.114, G.115, K.116
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:K.22, A:V.25, A:T.110
- Water bridges: A:L.114
BOG.8: 7 residues within 4Å:- Chain B: L.131, A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.10
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:L.131, B:A.134
- Hydrogen bonds: B:S.135, B:Q.139
- Water bridges: B:S.135, B:S.135
BOG.9: 6 residues within 4Å:- Chain B: K.22, V.25, T.110, L.114, G.115, K.116
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:K.22, B:V.25, B:T.110
- Water bridges: B:L.114
BOG.13: 7 residues within 4Å:- Chain C: L.131, A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.15
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.131, C:A.134
- Hydrogen bonds: C:S.135, C:Q.139
- Water bridges: C:S.135, C:S.135
BOG.14: 6 residues within 4Å:- Chain C: K.22, V.25, T.110, L.114, G.115, K.116
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:K.22, C:V.25, C:T.110
- Water bridges: C:L.114
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.5: 7 residues within 4Å:- Chain A: M.97, H.98, V.101, L.131, P.132, S.135
- Ligands: BOG.3
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.135
- Water bridges: A:H.98, A:S.135
PG4.10: 7 residues within 4Å:- Chain B: M.97, H.98, V.101, L.131, P.132, S.135
- Ligands: BOG.8
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.135
- Water bridges: B:H.98, B:S.135
PG4.15: 7 residues within 4Å:- Chain C: M.97, H.98, V.101, L.131, P.132, S.135
- Ligands: BOG.13
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:S.135
- Water bridges: C:H.98, C:S.135
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luz, J.G. et al., Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem. (2015)
- Release Date
- 2015-07-08
- Peptides
- Prostaglandin E synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.41 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x 4U9: 5-[4-bromo-2-(2-chloro-6-fluorophenyl)-1H-imidazol-5-yl]-2-{[4-(trifluoromethyl)phenyl]ethynyl}pyridine(Non-covalent)
- 3 x GSH: GLUTATHIONE(Non-covalent)
- 6 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luz, J.G. et al., Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem. (2015)
- Release Date
- 2015-07-08
- Peptides
- Prostaglandin E synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.